|
 |
| |
Summary |
| |
| Description |
NKCP Nattokinase is a standardized
extract of Bacillus Subtilis Natto Culture,
a good bacteria found in the traditional Japanese delicacy
called natto — fermented soybeans. The vitamin
K2 content is also largely removed
so that NKCP is compatible with anticoagulant medications
such as Warfarin. NKCP tablets are odourless, easy
to swallow, and contain no genetically modified ingredients. |
| Development |
NKCP Nattokinase was developed and is manufactured
by Daiwa Pharmaceutical Co. Ltd. in Japan, a small
and innovative pharmaceutical company dedicated to
producing natural food extracts and supplements for
health and well being. Daiwa Pharmaceutical is renowned
for being the developer and manufacturer of immune
system supplement BioBran MGN-3. |
| Function |
There a a number of enzymes that have
been identified by Daiwa Pharmaceutical in NKCP natto
extract, including Nattokinase, which have been shown
to inactivate an unhealthy enzyme in the blood called
plasminogen activator inhibitor (PAI-1), which increases
as we get older. By helping to reduce PAI-1, NKCP greatly
increases the efficiency of our body's natural control
mechanisms for blood viscosity. The breakthrough with
NKCP is that it has no medicinal effect — it
does not directly act upon blood viscosity and does
not directly dissolve blood clots. Rather, NKCP merely
increases the efficiency of the body's own blood-control
mechanisms. This means that this natural food supplement
does not adversely affect blood coagulation — something
that can happen using medicinal blood thinners such
as aspirin. |
| Safety |
NKCP Nattokinase safety has been confirmed by extensive
testing, including independent safety examinations
concerning acute toxicity, sub acute toxicity, mutagenicity,
antigenicity and overdose. However, as with any food
supplement, if you have a specific medical condition
or are taking medication (especially relating to thrombosis
or blood circulation), you are advised to consult with
your doctor before taking NKCP Nattokinase. |
| Standard Dose |
Base on evaluation of effectiveness
and overdose tests on human, 250-500mg of NKCP (2-4
tablets) is recommended as the standard dose per day,
taken after the evening meal. |
|
| |
| |
|
|
